A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor immune microenvironment (TIME) plays a critical role in the progression of ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

On Jan. 24, the FDA issued a warning about the enzyme deficiency in which it urged health care providers to “inform patients prior to treatment” about the risks of taking 5-FU and capecitabine. On ...

How often do you take capecitabine and temozolomide? You take capecitabine and temozolomide as cycles of treatment. This means you take the drugs and then have a rest to allow your body to recover.

Treatment with metronomic capecitabine plus an aromatase inhibitor (AI) demonstrated improvements in both progression-free survival (PFS) and overall survival (OS) among patients with hormone receptor ...

PURPOSEThis phase 3 trial aimed to compare the efficacy and safety of capecitabine or capecitabine plus oxaliplatin (XELOX) with those of fluorouracil plus cisplatin (PF) in definitive concurrent ...

Global Capecitabine Market Global Capecitabine Market Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2024" report has been added to ResearchAndMarkets.com's ...

Global Capecitabine Market Global Capecitabine Market Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering ...

Capecitabine is a chemotherapy drug sold under the brand name Xeloda. It’s sometimes used as a treatment for gallbladder cancer.

Several systemic treatments are approved or recommended by guidelines for advanced well-differentiated neuroendocrine tumors (NETs). These include somatostatin analogs, everolimus (Afinitor), ...